Related Experiment Video
Updated: May 15, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
Serum hepcidin levels and iron parameters in children with iron deficiency
Hyoung Soo Choi1, Sang Hoon Song, Jae Hee Lee
1Department of Pediatrics, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Insights
Serum hepcidin levels can help diagnose iron deficiency (ID) in children. This study found hepcidin levels significantly correlate with iron status, suggesting its potential as a diagnostic indicator.
Area of Science:
- Pediatric Nutrition
- Clinical Biochemistry
- Hematology
Background:
- Iron deficiency (ID) and iron deficiency anemia (IDA) are prevalent nutritional disorders in children.
- Hepcidin, a hepatic peptide hormone, is a key regulator of systemic iron metabolism.
- The diagnostic utility of serum hepcidin levels for ID in pediatric populations requires investigation.
Purpose of the Study:
- To evaluate the efficacy of serum hepcidin levels in diagnosing iron deficiency in children.
- To assess the correlation between serum hepcidin and established iron status parameters.
- To determine the diagnostic accuracy of serum hepcidin for identifying ID in pediatric patients.
Main Methods:
- Serum samples from 59 children (aged 5 months to 17 years) were analyzed for hepcidin-25 using ELISA.
- Participants were categorized into three groups: IDA (N=17), ID (N=18), and controls (N=24) based on hemoglobin and iron parameters.
- Statistical analyses were performed to compare hepcidin levels and assess diagnostic performance.
Main Results:
- Significant differences in serum hepcidin, ferritin, sTfR, transferrin saturation, and hemoglobin were observed across groups (P<0.0001).
- Serum hepcidin levels were markedly lower in IDA and ID groups compared to controls.
- Receiver operating characteristic analysis indicated serum hepcidin as a useful predictor of ID, with a cutoff of ≤6.895 ng/mL showing 79.2% sensitivity and 82.8% specificity.
Conclusions:
- Serum hepcidin levels are significantly associated with iron status in children.
- Hepcidin demonstrates potential as a valuable biomarker for diagnosing iron deficiency in pediatric populations.
- Further research is warranted to validate these findings and establish definitive cutoff values for clinical application.
Background:
Iron deficiency (ID) and iron deficiency anemia (IDA) are common nutritional disorders in children. Hepcidin, a peptide hormone produced in the liver, is a central regulator of systemic iron metabolism. We evaluated whether serum hepcidin levels can diagnose ID in children.
Methods:
Sera from 59 children (23 males and 36 females; 5 months to 17 years) were analyzed for hepcidin-25 by ELISA. Patients were classified according to hemoglobin level and iron parameters as: IDA, (N=17), ID (N=18), and control (N=24).
Results:
Serum hepcidin, ferritin, soluble transferrin receptor (sTfR), transferrin saturation, and hemoglobin levels differed significantly between groups (P<0.0001). Serum hepcidin and ferritin levels (mean±SD) were 2.01±2.30 and 7.00±7.86, 7.72±8.03 and 29.35±24.01, 16.71±14.74 and 46.40±43.57 ng/mL in the IDA, ID, and control groups, respectively. The area under the receiver operating characteristic curve for serum hepcidin as a predictor of ID was 0.852 (95% CI, 0.755-0.950). Hepcidin ≤6.895 ng/mL had a sensitivity of 79.2% and specificity of 82.8% for the diagnosis of ID. Serum hepcidin levels were significantly correlated with ferritin, transferrin saturation, and hemoglobin levels and significantly negatively correlated with sTfR level and total iron binding capacity (P<0.0001).
Conclusion:
Serum hepcidin levels are significantly associated with iron status and can be a useful indicator of ID. Further studies are necessary to validate these findings and determine a reliable cutoff value in children.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
The Periodic Table and Organismal Elements
Serum Studies: Renal Function Tests

